本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

16.91
+0.23001.38%
盤後16.910.00000.00%16:05 EDT
成交量:142.66萬
成交額:2,406.50萬
市值:17.78億
市盈率:-11.68
高:17.30
開:16.64
低:16.05
收:16.68
資料載入中...
2023/06/12

重要事件披露

Form 8-K - Current report
2023/05/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/06

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/09/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

重要事件披露

8-K - Current report